港股詳情

本页面由TTMF Limited提供服务

邁威生物-B待上市

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：4.00億

香港流通股本：4.00億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

1

开始申购

04/20

2

申購截止

04/23 10:15

3

公布中签

04/24

4

暗盘

04/27 16:15 - 18:30

5

挂牌上市

04/28

總覽公司新聞資訊公告

股份發售

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02493/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02493","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"邁威生物-B","latestPrice":0,"timestamp":1776672000000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":400000000,"shares":400000000,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"04-20 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":8,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1776648600000,1776657600000],[1776661200000,1776672000000]],"volumeRatio":0,"ipoDetail":{"name":"迈威生物－Ｂ","exchange":"SEHK","listingDate":"2026-04-28","sharesOutstanding":446730200,"sharesFloat":446730200,"offerAmount":47130200,"priceRange":"27.640 - 30.710","market":"HK","openProspectusDate":"2026-04-20","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0420/2026042000012_c.pdf","purchaseBeginDate":"2026-04-20","purchaseEndDate":"2026-04-23","winningDate":"2026-04-27","currency":"HKD","minPurchaseQuantity":200,"peRate":-12.17,"use":"1、约56.8%，或713.0百万港元将用于核心产品9MW2821针对多种适用症不同阶段的临床开发试验；\n2、约17.7%，或222.3百万港元将用于针对具有大量临床需求的肿瘤和年龄相关疾病的其他管线产品的研发；\n3、约15.5%，或194.7百万港元将用于商业化目的；\n4、约10.0%，或125.6百万港元将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司成立于2017年，是一家以药物研发方面的创新能力以及从药物发现至商业化销售的端到端能力而闻名的中国制药公司。公司主要专注于自主开发肿瘤、免疫、眼科、骨科等领域的药物。公司建立了管线产品组合，包括10个以上不同品种的药物资产，包括一款自研核心产品9MW2821（bulumtatug fuvedotin （「BFv」），靶向Nectin-4的ADC候选药物）。","subscribed":19.83,"marketCap":12348000000,"minimumCapital":6203.95,"overAllotment":false,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2356600","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-04-27","greyDateTimestamp":1777219200000,"greyOpeningTime":1777277700000,"greyClosingTime":1777285800000,"showGreyQuote":false,"openProspectusDate":"2026-04-20","listingDate":"2026-04-28"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","floatShares":400000000,"roa":"--","roe":"--","lyrEps":0,"shares":400000000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/02493\",,undefined,":{"id":9896,"type":"COMMON","ipoName":"02493-IPO","symbol":"02493","companyName":"邁威生物-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"中信證券(香港)有限公司","lotSize":200,"minQty":200,"expectedOfferingSize":47130200,"openingDate":1776648600000,"closingDate":1776910500000,"commonClosingDate":1776910500000,"allotmentDate":1776960000000,"listDate":1777305600000,"marginable":true,"marginRate":10,"latestPrice":30.71,"minPrice":27.64,"maxPrice":30.71,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0420/2026042000012_c.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2356600],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1776873600000,"interestEndDate":1776873600000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1777277700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"02493-IPO","ipoId":9896,"financingId":59183,"type":1,"availableFundLimit":6203.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":62039.4,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1776648600000,"closeTime":1776910500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":6203.94,"threshold":50000000000,"isAvailable":false},{"ipoName":"02493-IPO","ipoId":9896,"financingId":59176,"type":4,"availableFundLimit":6203.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1776648600000,"closeTime":1776910500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":6203.94,"threshold":50000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"FINANCING","closeTime":1776910500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":6203.94},{"method":"CASH","closeTime":1776910500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":6203.94}],"latestClosingDate":1776910500000,"subscribedFinanceRatio":19.83,"subscribedRatio":19.83,"forecastRatio":28.75,"raiseMoney":144740000,"totalMargin":2870590000,"quoteInfoUpdatedAt":1776705888259,"forecastMarketValue":13033353585,"minForecastMarketValue":12347622728,"maxForecastMarketValue":13719084442,"sharesOutstanding":446730200,"business":"公司成立於2017年，是一家以藥物研發方面的創新能力以及從藥物發現至商業化銷售的端到端能力而聞名的中國製藥公司。公司主要專註於自主開發腫瘤、免疫、眼科、骨科等領域的藥物。公司建立了管線產品組合，包括10個以上不同品種的藥物資產，包括一款自研核心產品9MW2821（bulumtatug fuvedotin （「BFv」），靶向Nectin-4的ADC候選藥物）。","greyOpeningTime":1777277700000,"greyClosingTime":1777285800000,"tradable":true,"showClawback":true,"clawbackType":"機制B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"02493\",pageSize:20,pageCount:1,market:\"hk\",,,undefined,":[{"items":[{"cdn_pdf":true,"hasAttachments":false,"id":"21028802","market":"hk","labels":[],"media":"港交所","original_id":"N.HK49nYLE3dL9","pdf_url":"https://static.tigerbbs.com/177fb31970f24859a2a215dc52babeeb","pub_time":1776637020000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球發售","symbol":"02493","title":"全球發售","titleType":"股份發售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0420/2026042000012_c.pdf","us_notice_code":"上市文件 - [發售以供認購]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份發售","pubTime":"2026-04-20 06:17","pubTimestamp":1776637020,"notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}